[go: up one dir, main page]

LU73993A1 - - Google Patents

Info

Publication number
LU73993A1
LU73993A1 LU73993A LU73993A LU73993A1 LU 73993 A1 LU73993 A1 LU 73993A1 LU 73993 A LU73993 A LU 73993A LU 73993 A LU73993 A LU 73993A LU 73993 A1 LU73993 A1 LU 73993A1
Authority
LU
Luxembourg
Application number
LU73993A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU73993A1 publication Critical patent/LU73993A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LU73993A 1974-12-13 1975-12-11 LU73993A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2458965A DE2458965C3 (de) 1974-12-13 1974-12-13 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
LU73993A1 true LU73993A1 (xx) 1976-11-11

Family

ID=5933305

Family Applications (1)

Application Number Title Priority Date Filing Date
LU73993A LU73993A1 (xx) 1974-12-13 1975-12-11

Country Status (27)

Country Link
US (1) US4051252A (xx)
JP (1) JPS5182266A (xx)
AT (1) AT343653B (xx)
BE (1) BE836528A (xx)
CA (1) CA1059523A (xx)
CH (1) CH622250A5 (xx)
CS (1) CS189731B2 (xx)
DD (1) DD125484A5 (xx)
DE (1) DE2458965C3 (xx)
DK (1) DK137082C (xx)
ES (1) ES443429A1 (xx)
FI (1) FI753493A (xx)
FR (1) FR2293928A1 (xx)
GB (1) GB1490306A (xx)
HK (1) HK52580A (xx)
HU (1) HU173557B (xx)
IE (1) IE42208B1 (xx)
IL (1) IL48642A (xx)
KE (1) KE3078A (xx)
LU (1) LU73993A1 (xx)
NL (1) NL7514521A (xx)
NO (1) NO145382C (xx)
PL (1) PL99858B1 (xx)
SE (1) SE419645B (xx)
SU (1) SU604487A3 (xx)
YU (1) YU315275A (xx)
ZA (1) ZA757777B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431657A (en) * 1982-05-24 1984-02-14 Ayerst, Mckenna & Harrison Inc. Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
KR20010086657A (ko) * 2000-03-02 2001-09-15 성재갑 아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
SI1318997T1 (sl) * 2000-09-15 2006-12-31 Vertex Pharma Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
PT1317448E (pt) * 2000-09-15 2005-08-31 Vertex Pharma Compostos de pirazole uteis como inibidores de proteina-quinase
CN1926132B (zh) * 2000-09-15 2010-12-29 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的吡唑化合物
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
CN100408573C (zh) 2000-12-21 2008-08-06 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的吡唑化合物
KR100406634B1 (ko) * 2001-03-12 2003-11-20 주식회사 엘지생명과학 3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
CA2460145C (en) 2001-09-26 2011-04-26 Pharmacia Italia S.P.A. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
EP2322521B1 (en) * 2002-02-06 2013-09-04 Vertex Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of GSK-3
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
WO2003078427A1 (en) 2002-03-15 2003-09-25 Vertex Pharmaceuticals, Inc. Azolylaminoazines as inhibitors of protein kinases
ES2411655T3 (es) 2002-05-17 2013-07-08 Pfizer Italia S.R.L. Derivados de aminoindazol activos como inhibidores de quinasas, procedimiento para su preparación y composiciones farmacéuticas que los comprenden
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
ATE339419T1 (de) 2002-08-02 2006-10-15 Vertex Pharma Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren
WO2004041285A1 (en) * 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
US7601718B2 (en) 2003-02-06 2009-10-13 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
WO2005056547A2 (en) * 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
DE102004005172A1 (de) * 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
AU2006279376B2 (en) 2005-08-18 2011-04-14 Vertex Pharmaceuticals Incoporated Pyrazine kinase inhibitors
EP1954277B1 (en) 2005-11-03 2017-01-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
JP2009533474A (ja) * 2006-04-14 2009-09-17 アボット・ラボラトリーズ バニロイドサブタイプ1(vr1)受容体を阻害するインダゾリルウレアの製造方法
NZ576750A (en) 2006-11-02 2012-01-12 Vertex Pharma Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
CA2673353A1 (en) 2006-12-19 2008-06-26 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
CN101663295B (zh) 2007-03-09 2014-11-05 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的氨基嘧啶类化合物
ES2374335T3 (es) 2007-03-09 2012-02-15 Vertex Pharmaceuticals Incorporated Aminopirimidinas útiles como inhibidores de proteína quinasas.
CA2679701A1 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyridines useful as inhibitors of protein kinases
WO2008128009A2 (en) 2007-04-13 2008-10-23 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
EP2152696B1 (en) 2007-05-02 2014-09-24 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
WO2008137622A2 (en) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
JP5389785B2 (ja) * 2007-05-02 2014-01-15 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼ阻害剤として有用なチアゾールおよびピラゾール
CA2687966A1 (en) * 2007-05-24 2008-12-04 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
WO2009018415A1 (en) 2007-07-31 2009-02-05 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
RU2011112802A (ru) * 2008-09-03 2012-10-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Сокристаллы и содержащие их фармацевтические композиции
DE102009004245A1 (de) 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
WO2014017936A2 (en) 2012-07-24 2014-01-30 Bial- Portela & Ca, S.A. Urea compounds and their use as enzyme inhibitors
US20150197503A1 (en) * 2012-07-27 2015-07-16 Bial-Portela & Cª, S.A. Process for the synthesis of substituted urea compounds
JP6449277B2 (ja) 2013-07-24 2019-01-09 ビアル−ポルテラ エ コンパニア,ソシエダッド アノニマ イミダゾールカルボキサミドおよびfaah阻害剤としてのそれらの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133081A (en) * 1964-05-12 J-aminoindazole derivatives
CH397698A (de) * 1961-09-08 1965-08-31 Siegfried Ag Verfahren zur Herstellung neuer 1-Carbamyl-indazole
US3274203A (en) * 1963-05-31 1966-09-20 Du Pont 1-carbamyl and thiocarbamyl-3-amino-4-nonsubstituted and substituted pyrazoles
NL6707299A (xx) * 1966-07-16 1968-01-17
DE1770649A1 (de) * 1968-06-15 1971-11-11 Bayer Ag Substituierte 3-Amino-indazole

Also Published As

Publication number Publication date
IE42208B1 (en) 1980-06-18
IL48642A (en) 1979-12-30
DD125484A5 (xx) 1977-04-20
JPS5182266A (en) 1976-07-19
US4051252A (en) 1977-09-27
IL48642A0 (en) 1976-02-29
ATA939775A (de) 1977-10-15
NO145382B (no) 1981-11-30
HU173557B (hu) 1979-06-28
SE7513990L (sv) 1976-06-14
CA1059523A (en) 1979-07-31
FI753493A (xx) 1976-06-14
BE836528A (fr) 1976-06-11
DK137082B (da) 1978-01-16
DE2458965A1 (de) 1976-06-16
ES443429A1 (es) 1977-04-16
FR2293928A1 (fr) 1976-07-09
DK567275A (da) 1976-06-14
HK52580A (en) 1980-09-26
ZA757777B (en) 1976-11-24
YU315275A (en) 1982-02-28
AT343653B (de) 1978-06-12
AU8717075A (en) 1977-06-09
CS189731B2 (en) 1979-04-30
PL99858B1 (pl) 1978-08-31
NO145382C (no) 1982-03-10
NL7514521A (nl) 1976-06-15
DK137082C (da) 1978-06-19
GB1490306A (en) 1977-11-02
DE2458965C3 (de) 1979-10-11
NO754024L (xx) 1976-06-15
DE2458965B2 (de) 1979-02-22
SE419645B (sv) 1981-08-17
KE3078A (en) 1980-10-03
SU604487A3 (ru) 1978-04-25
IE42208L (en) 1976-06-13
CH622250A5 (xx) 1981-03-31
FR2293928B1 (xx) 1979-09-21

Similar Documents

Publication Publication Date Title
FR2267330B1 (xx)
FR2293928B1 (xx)
USB450870I5 (xx)
DK62375A (xx)
CS178194B2 (xx)
FR2260332B1 (xx)
AU7459074A (xx)
DK137648C (xx)
AU485556B2 (xx)
FR2262992B1 (xx)
FR2273124B1 (xx)
CS169396B1 (xx)
BG19643A1 (xx)
AU481119A (xx)
BE826215A (xx)
BG20731A1 (xx)
BG19656A1 (xx)
BG19692A1 (xx)
BG19728A1 (xx)
AU481639A (xx)
AU481545A (xx)
BG19746A1 (xx)
BG19931A1 (xx)
BG19966A1 (xx)
DD117704A5 (xx)